Literature DB >> 21277625

Future therapies for food allergies.

Anna Nowak-Węgrzyn1, Hugh A Sampson.   

Abstract

Food allergy is an increasingly prevalent problem in westernized countries, and there is an unmet medical need for an effective form of therapy. A number of therapeutic strategies are under investigation targeting foods that most frequently provoke severe IgE-mediated anaphylactic reactions (peanut, tree nuts, and shellfish) or are most common in children, such as cow's milk and hen's egg. Approaches being pursued are both food allergen specific and nonspecific. Allergen-specific approaches include oral, sublingual, and epicutaneous immunotherapy (desensitization) with native food allergens and mutated recombinant proteins, which have decreased IgE-binding activity, coadministered within heat-killed Escherichia coli to generate maximum immune response. Diets containing extensively heated (baked) milk and egg represent an alternative approach to food oral immunotherapy and are already changing the paradigm of strict dietary avoidance for patients with food allergy. Nonspecific approaches include monoclonal anti-IgE antibodies, which might increase the threshold dose for food allergen in patients with food allergy, and a Chinese herbal formulation, which prevented peanut-induced anaphylaxis in a murine model and is currently being investigated in clinical trials. The variety of strategies for treating food allergy increases the likelihood of success and gives hope that accomplishing an effective therapy for food allergy is within reach.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21277625      PMCID: PMC3066474          DOI: 10.1016/j.jaci.2010.12.1098

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  108 in total

1.  Further fatalities caused by anaphylactic reactions to food, 2001-2006.

Authors:  S Allan Bock; Anne Muñoz-Furlong; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2007-02-15       Impact factor: 10.793

2.  Specific oral tolerance induction in children with very severe cow's milk-induced reactions.

Authors:  Giorgio Longo; Egidio Barbi; Irene Berti; Rosanna Meneghetti; Angela Pittalis; Luca Ronfani; Alessandro Ventura
Journal:  J Allergy Clin Immunol       Date:  2007-12-26       Impact factor: 10.793

3.  A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

Authors:  Hugh A Sampson; Donald Y M Leung; A Wesley Burks; Gideon Lack; Sami L Bahna; Stacie M Jones; Dennis A Wong
Journal:  J Allergy Clin Immunol       Date:  2011-03-11       Impact factor: 10.793

4.  Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model.

Authors:  Xiu-Min Li; Kamal Srivastava; James W Huleatt; Kim Bottomly; A Wesley Burks; Hugh A Sampson
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

5.  Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy.

Authors:  Satya D Narisety; Justin M Skripak; Pamela Steele; Robert G Hamilton; Elizabeth C Matsui; A Wesley Burks; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2009-08-08       Impact factor: 10.793

6.  Identification of IgE- and IgG-binding epitopes on alpha(s1)-casein: differences in patients with persistent and transient cow's milk allergy.

Authors:  P Chatchatee; K M Järvinen; L Bardina; K Beyer; H A Sampson
Journal:  J Allergy Clin Immunol       Date:  2001-02       Impact factor: 10.793

7.  B-cell epitopes as a screening instrument for persistent cow's milk allergy.

Authors:  Kirsi-Marjut Järvinen; Kirsten Beyer; Leticia Vila; Pantipa Chatchatee; Paula J Busse; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2002-08       Impact factor: 10.793

8.  Household peanut consumption as a risk factor for the development of peanut allergy.

Authors:  Adam T Fox; Peter Sasieni; George du Toit; Huma Syed; Gideon Lack
Journal:  J Allergy Clin Immunol       Date:  2009-02       Impact factor: 10.793

9.  Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein.

Authors:  Wayne G Shreffler; Niya Wanich; Marla Moloney; Anna Nowak-Wegrzyn; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2009-01       Impact factor: 10.793

10.  Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-gamma.

Authors:  C Qu; K Srivastava; J Ko; T F Zhang; H A Sampson; X-M Li
Journal:  Clin Exp Allergy       Date:  2007-06       Impact factor: 5.018

View more
  62 in total

Review 1.  The future of food allergy therapeutics.

Authors:  Michele Henson; A Wesley Burks
Journal:  Semin Immunopathol       Date:  2012-06-27       Impact factor: 9.623

2.  Introducing solid food: age of introduction and its effect on risk of food allergy and other atopic diseases.

Authors:  Elissa Michele Abrams; Allan B Becker
Journal:  Can Fam Physician       Date:  2013-07       Impact factor: 3.275

3.  Oral immunotherapy for treatment of egg allergy in children.

Authors:  A Wesley Burks; Stacie M Jones; Robert A Wood; David M Fleischer; Scott H Sicherer; Robert W Lindblad; Donald Stablein; Alice K Henning; Brian P Vickery; Andrew H Liu; Amy M Scurlock; Wayne G Shreffler; Marshall Plaut; Hugh A Sampson
Journal:  N Engl J Med       Date:  2012-07-19       Impact factor: 91.245

Review 4.  Murine models for mucosal tolerance in allergy.

Authors:  Ursula Smole; Irma Schabussova; Winfried F Pickl; Ursula Wiedermann
Journal:  Semin Immunol       Date:  2017-08-12       Impact factor: 11.130

Review 5.  Immunotherapeutic approaches for the treatment of eosinophilic esophagitis.

Authors:  Antonella Cianferoni; Jonathan M Spergel
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

Review 6.  Peptide and Recombinant Allergen Vaccines for Food Allergy.

Authors:  Quindelyn S Cook; A Wesley Burks
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

Review 7.  Advances in immunotherapy for food allergy.

Authors:  Yamini V Virkud; Brian P Vickery
Journal:  Discov Med       Date:  2012-09       Impact factor: 2.970

Review 8.  Novel approaches to food allergy.

Authors:  Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

9.  Predicting food challenge outcomes for baked milk: role of specific IgE and skin prick testing.

Authors:  Lisa M Bartnikas; William J Sheehan; Elaine B Hoffman; Perdita Permaul; Anahita F Dioun; James Friedlander; Sachin N Baxi; Lynda C Schneider; Wanda Phipatanakul
Journal:  Ann Allergy Asthma Immunol       Date:  2012-08-21       Impact factor: 6.347

Review 10.  Oral Immunotherapy for Treatment of Immunoglobulin E-Mediated Food Allergy: The Transition to Clinical Practice.

Authors:  Giovanni B Pajno; Linda Cox; Lucia Caminiti; Vincenzo Ramistella; Giuseppe Crisafulli
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-06-01       Impact factor: 1.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.